Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Clinical trial NCT00244257 · TERMINATED

Trial details

NCT number: NCT00244257
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura

Start date: 2005-08-01
Primary completion: 2008-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.